跳至主要内容
临床试验/NCT00191204
NCT00191204已完成3 期

Long Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence

Eli Lilly and Company2 个研究点 分布在 1 个国家目标入组 363 人开始时间: 2001年9月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
363
试验地点
2
主要终点
The primary objective of this study is to generate long-term safety data for duloxetine in the treatment of women with stress urinary incontinence.

研究概览

简要总结

The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female out patients
  • Are ambulatory and are able to use a toilet independently and without difficulty.

排除标准

  • Use of monoamine oxidase inhibitors (MAOIs)

结局指标

主要结局

The primary objective of this study is to generate long-term safety data for duloxetine in the treatment of women with stress urinary incontinence.

次要结局

  • The secondary objective of this study is to collect data to demonstrate the maintenance of effect of duloxetine on patients quality of life, measured by Patient Impression of Improvement questionnaire.

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验